Annals of Research in Oncology

“The importance of timely nutritional assessment in oncology is often underestimated by both patients and clinicians, with only one in three cancer patients in Europe receiving nutritional support during treatments”. 👉🏻 Considerando che la malnutrizione è estremamente frequente nei pazienti oncologici, compromettendo risposta alle terapie, qualità di vita e sopravvivenza. È tempo che la nutrizione diventi parte integrante del percorso oncologico, non un aspetto secondario. 🫱🏻🫲🏼 È fondamentale che i professionisti sanitari integrino lo screening nutrizionale nella pratica clinica, riconoscendo che un adeguato supporto nutrizionale non è un'opzione ma una necessità terapeutica. Solo con un approccio multidisciplinare che valorizzi anche l'aspetto nutrizionale potremo offrire ai pazienti oncologici un percorso di cura veramente completo ed efficace. #malnutrizione #oncologia #nutrizione #valutazionenutrizionale #screeningnutrizionale

📢 𝗧𝗵𝗲 𝗶𝗺𝗽𝗮𝗰𝘁 𝗼𝗳 𝗺𝗮𝗹𝗻𝘂𝘁𝗿𝗶𝘁𝗶𝗼𝗻 𝗶𝗻 𝗰𝗮𝗻𝗰𝗲𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 #Malnutrition is a serious pathological condition resulting from inadequate nutrient intake, absorption, or utilization. It is highly prevalent among cancer patients, affecting between 20-70% depending on tumor type and disease stage. Studies indicate that nearly 50% of gastrointestinal cancer patients, over 45% of head and neck cancer patients, and over 40% of lung cancer patients experience malnutrition. Alarmingly, 𝗮𝗹𝗺𝗼𝘀𝘁 𝟮𝟬% 𝗼𝗳 𝗰𝗮𝗻𝗰𝗲𝗿-𝗿𝗲𝗹𝗮𝘁𝗲𝗱 𝗱𝗲𝗮𝘁𝗵𝘀 𝗮𝗿𝗲 𝗮𝘁𝘁𝗿𝗶𝗯𝘂𝘁𝗲𝗱 𝘁𝗼 𝗺𝗮𝗹𝗻𝘂𝘁𝗿𝗶𝘁𝗶𝗼𝗻 𝗿𝗮𝘁𝗵𝗲𝗿 𝘁𝗵𝗮𝗻 𝘁𝗵𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗶𝘁𝘀𝗲𝗹𝗳. 🔎 The latest #Editorial authored by Professor Riccardo Caccialanza et al.* - Fondazione I.R.C.C.S. Policlinico San Matteo Pavia - explores the critical role of early nutritional assessment and intervention in improving patient outcomes and reducing healthcare burdens. Addressing malnutrition must be a priority in oncology care. 📌 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: https://lnkd.in/d_w5efpn EIC Professors Antonio Giordano, Sbarro Health Research Organization & 𝗖𝗮𝗿𝗺𝗶𝗻𝗲 𝗣𝗶𝗻𝘁𝗼, AUSL Reggio Emilia Executive Ed. Professor Francesca Pentimalli, Università LUM Edra S.p.A. * Drs. ALICE TARTARA, Valentina Da Prat, Elisa Mattavelli, 𝗙𝗿𝗮𝗻𝗰𝗲𝘀𝗰𝗮 𝗗𝗲 𝗦𝗶𝗺𝗲𝗶𝘀, 𝗟𝗼𝗿𝗲𝗻𝘇𝗼 𝗣𝗲𝗿𝗿𝗼𝗻𝗲, 𝗙𝗿𝗮𝗻𝗰𝗲𝘀𝗰𝗼 𝗦𝗲𝗿𝗿𝗮, Paolo Pedrazzoli Università di Pavia #Oncology #CancerCare #Malnutrition #MedicalResearch #Nutrition

🎉Excited to share our latest review: “New perspectives of selection tests for the treatment with PARPinhibitors of ovarian cancer patients” published in Annals of Research in Oncology! #OvarianCancer #PARPi #HRD #functionaltest

🔬 𝗦𝗲𝗹𝗲𝗰𝘁𝗶𝗼𝗻 𝗧𝗲𝘀𝘁𝘀 𝗳𝗼𝗿 𝗣𝗔𝗥𝗣 𝗜𝗻𝗵𝗶𝗯𝗶𝘁𝗼𝗿 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗶𝗻 𝗢𝘃𝗮𝗿𝗶𝗮𝗻 𝗖𝗮𝗻𝗰𝗲𝗿 PARP inhibitors have transformed the treatment of ovarian cancer, especially for patients with BRCA1/2 mutations. However, not all patients respond the same way, highlighting the need for better selection tests. Thanks to advances in molecular diagnostics, new tools are emerging to predict treatment response more accurately. One key factor? 𝗛𝗼𝗺𝗼𝗹𝗼𝗴𝗼𝘂𝘀 𝗿𝗲𝗰𝗼𝗺𝗯𝗶𝗻𝗮𝘁𝗶𝗼𝗻 𝗱𝗲𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆 (HRD), a dynamic process influenced by chemotherapy and resistance mechanisms. Traditional genetic tests may fall short in capturing these complexities. The latest Review authored by Dr. Benedetta Pellegrino et al. * explores cutting-edge 𝗛𝗥 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝗮𝗹𝗶𝘁𝘆 𝘁𝗲𝘀𝘁𝘀, including the 𝗥𝗔𝗗𝟱𝟭 𝗮𝘀𝘀𝗮𝘆, an innovative approach that assesses the dynamic nature of HR status. By integrating these tests into clinical practice, we can: ✅ Optimize patient selection ✅ Enhance treatment outcomes ✅ Minimize unnecessary toxicity 📌 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲: https://lnkd.in/d2SDkjZQ Editors in Chief, Professors Antonio Giordano, Sbarro Health Research Organization & 𝗖𝗮𝗿𝗺𝗶𝗻𝗲 𝗣𝗶𝗻𝘁𝗼, AUSL Reggio Emilia Executive Editor, Professor Francesca Pentimalli, Università LUM Edra S.p.A. #Oncology #PrecisionMedicine #PARPInhibitors #OvarianCancer #HRD * Drs. Chiara Tornali, 𝗠𝗮𝘁𝗶𝗹𝗱𝗲 𝗖𝗼𝗿𝗶𝗮𝗻ò, Chiara Tommasi, Alexandra Ingallinella, 𝗖𝗵𝗶𝗮𝗿𝗮 𝗖𝗮𝘀𝗮𝗿𝘁𝗲𝗹𝗹𝗶, Olga Serra, 𝗡𝗶𝗰𝗼𝗹𝗲𝘁𝘁𝗮 𝗖𝗮𝗺𝗽𝗮𝗻𝗶𝗻𝗶, 𝗚𝗮𝗶𝗮 𝗚𝗶𝗮𝗻𝗻𝗼𝗻𝗲, Lucia Musacchio, Michele Bartoletti, Antonino Musolino, Angelica Sikokis, 𝗗𝗮𝗻𝗶𝗲𝗹𝗲 𝗭𝗮𝗻𝗼𝗻𝗶. 

"PERSPECTIVES AND INNOVATION IN PEDIATRIC PSYCHO-ONCOLOGY: RESEARCH, ADVANCED THERAPIES, TECHNOLOGIES, AND NEW FRONTIERS" - just published with Annals of Research in Oncology 💡This perspective describes recent innovation, with these new insights being crucial for improving the overall #qualityoflife and long-term outcomes for patients and their families and for driving future research in pediatric psycho-oncology. In particular, it emphasizes the implementation of #neuropsychological screening tools to monitor and prevent cognitive decline in patients affected by central nervous system malignancies or those receiving neurotoxic treatments. Although #research is making great strides in the field of psycho-oncology, there are still too few shared clinical and scientific standards, especially on certain issues. In our opinion, the psychiatric management should be standardized. 💛We sincerely thank the children and parents we meet in daily clinical practice in #pediatriconcology. https://lnkd.in/dNCDcuSt #innovation #psychooncology #clinicalresearch Angela Mastronuzzi Dorella Scarponi Franca Fagioli Valentina Massaroni daniela chieffo Elisa Marconi SABRINA CIAPPINA Giulia Zucchetti

📢 𝗧𝗵𝗲 𝗹𝗮𝘁𝗲𝘀𝘁 𝗶𝘀𝘀𝘂𝗲 𝗼𝗳 𝗔𝗻𝗻𝗮𝗹𝘀 𝗼𝗳 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗶𝘀 𝗻𝗼𝘄 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗼𝗻𝗹𝗶𝗻𝗲! 𝗜𝗻 𝘁𝗵𝗶𝘀 𝗶𝘀𝘀𝘂𝗲: 𝗘𝗗𝗜𝗧𝗢𝗥𝗜𝗔𝗟 𝗡𝘂𝘁𝗿𝗶𝘁𝗶𝗼𝗻 𝗶𝗻 𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝘆: 𝘀𝘁𝗮𝘁𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗮𝗿𝘁 𝗮𝗻𝗱 𝗳𝘂𝘁𝘂𝗿𝗲 𝗽𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲𝘀 https://lnkd.in/d_w5efpn Dr. Riccardo Caccialanza et al. 𝗥𝗘𝗩𝗜𝗘𝗪𝗦 𝗡𝗲𝘄 𝗽𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲𝘀 𝗼𝗳 𝘀𝗲𝗹𝗲𝗰𝘁𝗶𝗼𝗻 𝘁𝗲𝘀𝘁𝘀 𝗳𝗼𝗿 𝘁𝗵𝗲 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝘄𝗶𝘁𝗵 𝗣𝗔𝗥𝗣 𝗶𝗻𝗵𝗶𝗯𝗶𝘁𝗼𝗿𝘀 𝗼𝗳 𝗼𝘃𝗮𝗿𝗶𝗮𝗻 𝗰𝗮𝗻𝗰𝗲𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀: 𝗮 𝗺𝗶𝗻𝗶-𝗿𝗲𝘃𝗶𝗲𝘄 https://lnkd.in/d2SDkjZQ Dr. Benedetta Pellegrino et al. 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗼𝗳 𝗲𝗹𝗲𝗰𝘁𝗿𝗼𝗽𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗵𝘂𝗺𝗮𝗻 𝗮𝗻𝗱 𝘃𝗲𝘁𝗲𝗿𝗶𝗻𝗮𝗿𝘆 𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝘆 https://lnkd.in/d_fKu8Tr Dr. alfonso baldi 𝗖𝗔𝗦𝗘 𝗥𝗘𝗣𝗢𝗥𝗧 𝗟𝗮𝗿𝗴𝗲𝘀𝘁 𝗿𝗲𝗽𝗼𝗿𝘁𝗲𝗱 𝗰𝗮𝘀𝗲 𝗼𝗳 𝗰𝗮𝗿𝗰𝗶𝗻𝗼𝗺𝗮𝘁𝗼𝘂𝘀 𝗴𝗮𝗹𝗹𝗯𝗹𝗮𝗱𝗱𝗲𝗿 𝗮𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗲𝗱 𝘄𝗶𝘁𝗵 𝗶𝗻𝘁𝗿𝗮 𝗰𝗵𝗼𝗹𝗲𝗰𝘆𝘀𝘁𝗶𝗰 𝗽𝗮𝗽𝗶𝗹𝗹𝗮𝗿𝘆 𝗻𝗲𝗼𝗽𝗹𝗮𝘀𝗺 (𝗜𝗖𝗣𝗡) 𝘄𝗶𝘁𝗵 𝗯𝗿𝗶𝗲𝗳 𝗿𝗲𝘃𝗶𝗲𝘄 𝗼𝗳 𝘁𝗵𝗲 𝗹𝗶𝘁𝗲𝗿𝗮𝘁𝘂𝗿𝗲 https://lnkd.in/dymWyWMW Dr. 𝗬𝗲𝘀𝘄𝗮𝗻𝘁𝗵 𝗡 𝗣𝗘𝗥𝗦𝗣𝗘𝗖𝗧𝗜𝗩𝗘 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲𝘀 𝗮𝗻𝗱 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗽𝗲𝗱𝗶𝗮𝘁𝗿𝗶𝗰 𝗽𝘀𝘆𝗰𝗵𝗼-𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝘆: 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵, 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀, 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 𝗮𝗻𝗱 𝗻𝗲𝘄 𝗳𝗿𝗼𝗻𝘁𝗶𝗲𝗿𝘀 https://lnkd.in/dNCDcuSt Dr. Elisa Marconi et al. EIC Prof.s Antonio Giordano - Sbarro Health Research Organization & 𝗖𝗮𝗿𝗺𝗶𝗻𝗲 𝗣𝗶𝗻𝘁𝗼 - AUSL Reggio Emilia Executive Editor Prof. Francesca Pentimalli - Università LUM Edra S.p.A. 📌 𝗔𝗰𝗰𝗲𝘀𝘀 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗶𝘀𝘀𝘂𝗲 𝗵𝗲𝗿𝗲: https://lnkd.in/d5ggJNU3 #Oncology #CancerResearch #Oncologists #Medicine #CancerTherapy

📣 𝗩𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝗰𝗮𝗻𝗰𝗲𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀: 𝗮 𝗰𝗮𝗹𝗹 𝘁𝗼 𝗮𝗰𝘁𝗶𝗼𝗻 Oncology has made huge strides, not just in prolonging patients' lives, but in significantly enhancing their 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗼𝗳 𝗹𝗶𝗳𝗲 through better diagnostics, less invasive surgeries, and advanced therapies. However, 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻-related complications, often overlooked, remain a major risk. Recent findings highlight a concerning gap: only a fraction of oncologists feel confident in advising their patients on preventable infections, especially regarding timely 𝘃𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗶𝗼𝗻𝘀. For those who missed it, discover the #Editorial authored by Drs. Angioletta Lasagna, Domiziana Alaimo, Paolo Pedrazzoli - Università di Pavia, Fondazione I.R.C.C.S. Policlinico San Matteo Pavia - on why proactive infection prevention is critical in oncology today: 📌 https://lnkd.in/dbzrTxVb EIC Prof.s Antonio Giordano - Sbarro Health Research Organization & 𝗖𝗮𝗿𝗺𝗶𝗻𝗲 𝗣𝗶𝗻𝘁𝗼 - AUSL Reggio Emilia Executive Editor Prof. Francesca Pentimalli #Oncology #InfectionPrevention #PatientCare #Vaccination

🔬 Developments in #OvarianCancer research! 🌍 We are pleased to share the 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗥𝗲𝗽𝗼𝗿𝘁 from the 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗗𝗶𝗮𝗹𝗼𝗴𝘂𝗲 𝗼𝗻 𝗢𝘃𝗮𝗿𝗶𝗮𝗻 𝗖𝗮𝗻𝗰𝗲𝗿: 𝗙𝗿𝗼𝗺 𝗕𝗲𝗻𝗰𝗵 𝘁𝗼 𝗕𝗲𝗱𝘀𝗶𝗱𝗲, held live on May 22, 2024, at Temple University and the University of Messina. This event brought together leading experts in primary and clinical research to foster crucial discussions on ovarian cancer. The report offers a comprehensive overview of the latest advancements and outlines key directions for the future of ovarian cancer research. 📌 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗿𝗲𝗽𝗼𝗿𝘁 𝗵𝗲𝗿𝗲: https://lnkd.in/et5UAVgM #CancerResearch #OvarianCancerAwareness #MedicalResearch #InnovationInHealthcare EIC Prof. Antonio Giordano - Sbarro Health Research Organization & Prof. 𝗖𝗮𝗿𝗺𝗶𝗻𝗲 𝗣𝗶𝗻𝘁𝗼 - AUSL Reggio Emilia Executive Ed. Prof. Francesca Pentimalli - Università LUM Edra S.p.A. 𝗔𝘂𝘁𝗵𝗼𝗿𝘀: Canio Martinelli, Sharon Burk, Maria Cuomo, Margherita D'Angelo, Andrea Morrione, Luigi Alfano, Blandino Alfredo, 𝗦𝗲𝗿𝗴𝗶𝗼 𝗕𝗮𝗹𝗱𝗮𝗿𝗶, Riccardo Laudicella, 𝗡𝗶𝗰𝗼𝗹𝗮 𝗦𝗶𝗹𝘃𝗲𝘀𝘁𝗿𝗶𝘀, Fausto Omero, Stefano Pergolizzi, Silvana Parisi, Miriam Sciacca, Paolo Ceriani, 𝗔𝗹𝗳𝗿𝗲𝗱𝗼 𝗘𝗿𝗰𝗼𝗹𝗶, Antonio Giordano

Annals of Research in Oncology - New diagnostic procedures for lung cancer https://lnkd.in/d2kiV6hi Lucia Mangone Isabella Bisceglia Ana Maria Pezzarossi Chiara Pollorsi Fortunato Morabito Antonio Giordano Francesca Pentimalli #Cancer #LungCancer #CancerDiagnosis #CancerResearch #NSCLC #LymphNodeMetastases #Medicine #Health #Oncology #OncoDaily

💡 𝗟𝘂𝗻𝗴 𝗰𝗮𝗻𝗰𝗲𝗿: 𝗻𝗲𝘄 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗽𝗿𝗼𝗰𝗲𝗱𝘂𝗿𝗲𝘀 #Lung #cancer continues to be a disease with a poor prognosis as more than 50% of tumors are diagnosed at an advanced stage. New diagnostic procedures such as 𝗘𝗕𝗨𝗦-𝗧𝗕𝗡𝗔 (endobronchial ultrasound-guided transbronchial needle aspiration) could facilitate the early diagnosis of lymph node metastases, thus improving the selection of patients who are candidates for surgery. This population-based study appears to be able to confirm the usefulness of this approach. 📌 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗺𝗼𝗿𝗲 in the new 𝗡𝗮𝗿𝗿𝗮𝘁𝗶𝘃𝗲 𝗥𝗲𝘃𝗶𝗲𝘄 authored by Professor Lucia Mangone et al. *, AUSL Reggio Emilia: https://lnkd.in/eFUTFygg EIC Prof. Antonio Giordano - Sbarro Health Research Organization & Prof. 𝗖𝗮𝗿𝗺𝗶𝗻𝗲 𝗣𝗶𝗻𝘁𝗼 - AUSL Reggio Emilia Executive Ed. Prof. Francesca Pentimalli - Università LUM Edra S.p.A. #Oncology #Oncologists #Research #Cancer *  Drs. 𝗠𝗮𝘁𝘁𝗲𝗼 𝗙𝗼𝗻𝘁𝗮𝗻𝗮, 𝗙𝗿𝗮𝗻𝗰𝗲𝘀𝗰𝗼 𝗠𝗮𝗿𝗶𝗻𝗲𝗹𝗹𝗶, 𝗥𝗼𝗯𝗲𝗿𝘁𝗼 𝗣𝗶𝗿𝗼, 𝗘𝗹𝗲𝗼𝗻𝗼𝗿𝗮 𝗖𝗮𝘀𝗮𝗹𝗶𝗻𝗶, 𝗣𝗮𝘁𝗿𝗶𝘇𝗶𝗮 𝗥𝘂𝗴𝗴𝗶𝗲𝗿𝗼, Isabella Bisceglia, Ana Maria Pezzarossi, Maria Serena Simeone, 𝗠𝗮𝘁𝘁𝗲𝗼 𝗧𝗮𝗰𝗰𝗼𝗻𝗶, 𝗔𝗻𝗻𝗮 𝗠𝗼𝗰𝗲𝗹𝗹𝗶𝗻, 𝗦𝗶𝗺𝗼𝗻𝗲 𝗥𝗶𝘇𝘇𝗮𝘁𝗼, Chiara Pollorsi, Fortunato Morabito, 𝗡𝗶𝗰𝗼𝗹𝗮 𝗖𝗼𝘀𝗶𝗺𝗼 𝗙𝗮𝗰𝗰𝗶𝗼𝗹𝗼𝗻𝗴𝗼. Università degli Studi di Modena e Reggio Emilia AZIENDA OSPEDALIERA DI COSENZA